Advanced search
Publication Cover
Leukemia & Lymphoma Volume 52, 2011 - Issue 2
Submit an article Journal homepage
394
Views
17
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Clinical and biological features of t(4;14) multiple myeloma: a prospective study

Lionel KarlinImmuno-Hematology, Saint-Louis Hospital, Paris, France
,
Jean SoulierBiological Hematology, Saint-Louis Hospital, Paris, France
,
Olivia ChandesrisHematology, Necker Hospital, Paris, France
,
Sylvain ChoquetHematology, Pitie Salpetriere Hospital, Paris, France
,
Karim BelhadjHematology, Henri Mondor Hospital, Creteil, France
,
Margaret MacroHematology, Caen Hospital, Caen, France
,
Didier BouscaryHematology, Cochin Hospital, Paris, France
,
Raphael PorcherBiostatistics, Saint-Louis Hospital, Paris, France
,
David GhezHematology, Necker Hospital, Paris, France
,
Marion MalphettesImmuno-Hematology, Saint-Louis Hospital, Paris, France
,
Bouchra AsliImmuno-Hematology, Saint-Louis Hospital, Paris, France
,
Jean Claude BrouetImmuno-Hematology, Saint-Louis Hospital, Paris, France
,
Jean Christophe BoriesUniversity laboratory EA3963, Saint-Louis Hospital, Paris, France
,
Olivier HermineHematology, Necker Hospital, Paris, France
,
Jean Paul FermandImmuno-Hematology, Saint-Louis Hospital, Paris, France
&
Bertrand ArnulfCorrespondence[email protected]
 show all
Pages 238-246 | Received 25 Aug 2010, Accepted 02 Nov 2010, Published online: 24 Jan 2011

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Ping Wu, Brian A. Walker, Annemiek Broyl, Martin Kaiser, David C. Johnson, Rowan Kuiper, Mark van Duin, Walter M. Gregory, Faith E. Davies, Daniel Brewer, Dirk Hose, Pieter Sonneveld & Gareth J. Morgan. (2015) A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescue. Leukemia & Lymphoma 56:3, pages 594-601.
Read now
Morie A. Gertz. (2011) Deciding on the therapy of multiple myeloma using genetic risk stratification. Leukemia & Lymphoma 52:2, pages 157-158.
Read now

Articles from other publishers (15)

Susan Bal, Smith Giri, Kelly N. Godby & Luciano J. Costa. (2022) Revisiting the impact of immunoglobulin isotypes in multiple myeloma. Annals of Hematology 101:4, pages 825-829.
Crossref
Cristina Mansilla, Elena Soria, Miren Vallejo, Alberto Valiente, Aránzazu Perez-Juana, Amaya Zabalza, Guillermina Hurtado, Francisco Sala & Natalia Ramírez. (2018) Combined Selection System to Lower the Cutoff for Plasma Cell Enrichment Applied to iFISH Analysis in Multiple Myeloma. Translational Oncology 11:3, pages 647-652.
Crossref
Henry S. H. Chan, Christine I. Chen & Donna E. Reece. (2017) Current Review on High-Risk Multiple Myeloma. Current Hematologic Malignancy Reports 12:2, pages 96-108.
Crossref
Dean Smith & Kwee Yong. (2016) Advances in understanding prognosis in myeloma. British Journal of Haematology 175:3, pages 367-380.
Crossref
Javier Cid Ruzafa, Evie Merinopoulou, Rebecca F. Baggaley, Pamela Leighton, Winifred Werther, Diana Felici & Andrew Cox. (2016) Patient population with multiple myeloma and transitions across different lines of therapy in the USA: an epidemiologic model. Pharmacoepidemiology and Drug Safety 25:8, pages 871-879.
Crossref
Beata Holkova, Adriana Zingone, Maciej Kmieciak, Prithviraj Bose, Ashraf Z. Badros, Peter M. Voorhees, Rachid Baz, Neha Korde, Hui-Yi Lin, Jin-Qiu Chen, Michelle Herrmann, Liqiang Xi, Mark Raffeld, Xiuhua Zhao, Wen Wan, Mary Beth Tombes, Ellen Shrader, Caryn Weir-Wiggins, Heidi Sankala, Kevin T. Hogan, Austin Doyle, Christina M. Annunziata, Martha Wellons, John D. Roberts, Daniel Sullivan, Ola Landgren & Steven Grant. (2016) A Phase II Trial of AZD6244 (Selumetinib, ARRY-142886), an Oral MEK1/2 Inhibitor, in Relapsed/Refractory Multiple Myeloma. Clinical Cancer Research 22:5, pages 1067-1075.
Crossref
Michelle Dolan. 2016. Plasma Cell Neoplasms. Plasma Cell Neoplasms 79 99 .
Ji Zhang, XiaoJuan Xiao & Jing Liu. (2015) The role of circulating miRNAs in multiple myeloma. Science China Life Sciences 58:12, pages 1262-1269.
Crossref
Krzysztof Jamroziak, Ewa Wawrzyniak & El?bieta Iskierka. (2014) Znaczenie bortezomibu w leczeniu szpiczaka plazmocytowego u pacjent?w z ryzykiem cytogenetycznym. Acta Haematologica Polonica 45:3, pages 247-257.
Crossref
Etienne Crickx, Sebastian Wittnebel, Florence Pasquier, Alina Danu, Jean-Henri Bourhis, Vincent Ribrag, Francois Boué, Corinne Miceli, Xavier Mariette, Philippe Moreau, Stéphane de Botton & David Ghez. (2013) Dissociated responses to newer antimyeloma drugs identify a subset of refractory patients with an extremely poor prognosis. European Journal of Cancer 49:2, pages 411-415.
Crossref
Jing-jing Huang, Juan Yu, Jiang-yan Li, Yao-ting Liu & Ren-qian Zhong. (2012) Circulating microRNA expression is associated with genetic subtype and survival of multiple myeloma. Medical Oncology 29:4, pages 2402-2408.
Crossref
A Kalff & A Spencer. (2012) The t(4;14) translocation and FGFR3 overexpression in multiple myeloma: prognostic implications and current clinical strategies. Blood Cancer Journal 2:9, pages e89-e89.
Crossref
Liang Chu, Mack Y. Su, Leonard B. MaggiJr.Jr., Lan Lu, Chelsea Mullins, Seth Crosby, Gaofeng Huang, Wee Joo Chng, Ravi Vij & Michael H. Tomasson. (2012) Multiple myeloma–associated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stress. Journal of Clinical Investigation 122:8, pages 2793-2806.
Crossref
Marilyn L. Slovak. (2011) Multiple Myeloma: Current Perspectives. Clinics in Laboratory Medicine 31:4, pages 699-724.
Crossref
Macoura Gadji, Rhea Vallente, Ludger Klewes, Christiaan Righolt, Landon Wark, Narisorn Kongruttanachok, Hans Knecht & Sabine Mai. 2011. 77 126 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.